Amplia Therapeutics Limited Stock
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1300 AUD | 0.00% |
|
-3.70% | -13.33% |
| Market Cap | 66.73M 46.56M 40.86M 38.05M 35M 65.61M 4.45B 451M 177M 2.21B 175M 171M 7.62B | P/E 2027 * |
-5.65x | P/E 2028 * | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 51.23M 35.75M 31.37M 29.21M 26.87M 50.37M 3.42B 347M 136M 1.69B 134M 131M 5.85B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 4.52x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 week | -3.70% | ||
| Current month | -10.34% | ||
| 1 month | -13.33% | ||
| 3 months | -16.13% | ||
| Current year | -13.33% |
| 1 week | 0.12 |  | 0.14 |
| 1 month | 0.12 | | 0.16 |
| Current year | 0.1 | | 0.28 |
| 1 year | 0.1 | | 0.28 |
| 3 years | 0.05 | | 0.42 |
| 5 years | 0.05 | | 0.42 |
| 10 years | 0.04 | | 18.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-12-04 | |
Hamish George
DFI | Director of Finance/CFO | - | 2021-09-30 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 2015-09-01 |
Warwick Tong
CHM | Chairman | - | 2018-05-24 |
Jane Bell
CHM | Chairman | - | 2026-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/8/25 | Buy | Chairman | 152,174 | 0.0392% | ||
| 9/8/25 | Buy | Chairman | 336,826 | 0.0868% | ||
| 9/8/25 | Fiscal year | Founder | 535,000 | 0.1379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.70% | -44.68% | +49.43% | 46.56M | |
| -0.62% | +1.11% | +49.07% | +67.79% | 55.01B | |
| -1.32% | -2.71% | +34.27% | +77.57% | 54.24B | |
| +1.49% | +0.13% | -18.03% | -13.94% | 23.38B | |
| -0.57% | -4.13% | +2.34% | +387.73% | 22.57B | |
| +2.70% | +1.96% | +17.86% | -10.20% | 20.19B | |
| -0.64% | -0.84% | +29.18% | -32.01% | 17.86B | |
| -2.10% | -4.02% | +25.88% | +556.78% | 15.5B | |
| -6.69% | -5.11% | +169.13% | +304.89% | 14.2B | |
| +1.25% | +0.69% | +27.30% | +184.69% | 14.2B | |
| Average | -0.69% | -1.31% | +29.23% | +157.27% | 23.72B | |
| Weighted average by Cap. | -0.67% | -0.52% | +34.82% | +131.40% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 10M 6.98M 6.12M 5.7M 5.24M 9.83M 667M 67.65M 26.48M 331M 26.19M 25.63M 1.14B |
| Net income | -11.6M -8.09M -7.1M -6.61M -6.08M -11.4M -773M -78.47M -30.72M -383M -30.39M -29.73M -1.32B | -3.6M -2.51M -2.2M -2.05M -1.89M -3.54M -240M -24.35M -9.53M -119M -9.43M -9.23M -411M |
| Net Debt | -15.5M -10.81M -9.49M -8.84M -8.13M -15.24M -1.03B -105M -41.04M -512M -40.6M -39.72M -1.77B | -21.5M -15M -13.17M -12.26M -11.28M -21.14M -1.43B -145M -56.93M -711M -56.32M -55.1M -2.46B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-29 | A$0.1300 | 0.00% | 467,260 |
| 26-07-28 | A$0.1300 | 0.00% | 435,359 |
| 26-07-27 | A$0.1300 | -7.14% | 422,486 |
| 26-07-24 | A$0.1400 | +3.70% | 258,077 |
| 26-07-23 | A$0.1350 | 0.00% | 799,013 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1300AUD
Average target price
0.4200AUD
Spread / Average Target
+223.08%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
Select your edition
All financial news and data tailored to specific country editions
